A detailed history of Ballast Asset Management, LP transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Ballast Asset Management, LP holds 87,206 shares of COLL stock, worth $3.3 Million. This represents 1.34% of its overall portfolio holdings.

Number of Shares
87,206
Holding current value
$3.3 Million
% of portfolio
1.34%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

BUY
$24.67 - $30.44 $2.15 Million - $2.65 Million
87,206 New
87,206 $2.58 Billion

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.29B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Ballast Asset Management, LP Portfolio

Follow Ballast Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballast Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Ballast Asset Management, LP with notifications on news.